tiprankstipranks
Trending News
More News >
Immunome (IMNM)
NASDAQ:IMNM
US Market

Immunome (IMNM) Cash flow

Compare
268 Followers

Immunome Cash Flow

IMNM's free cash flow for Q4 2024 was $-43.44M. For the 2024 fiscal year, IMNM's free cash flow was decreased by $-109.57M and operating cash flow was $-42.06M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -110.79M$ -7.57M$ -28.69M$ -18.23M$ -12.13M
Investing Cash Flow
$ -85.06M$ -30.48M$ -248.00K$ -79.00K$ -586.00K
Financing Cash Flow
$ 240.53M$ 116.41M$ 32.00K$ 27.77M$ 49.94M
End Cash Position
$ 143.45M$ 98.78M$ 20.42M$ 49.33M$ 39.87M
Free Cash Flow
$ -117.97M$ -8.40M$ -28.94M$ -18.30M$ -12.72M
Currency in USD

Immunome Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis